Today: 9 April 2026
Vistry Group share price dips after buyback update as Rightmove flags record January jump
19 January 2026
1 min read

Vistry Group share price dips after buyback update as Rightmove flags record January jump

London, Jan 19, 2026, 14:36 GMT — Regular session

  • Vistry shares slipped in mid-afternoon London trading following a new buyback announcement
  • Rightmove’s report of a sharp rise in asking prices kept UK housing sentiment in the spotlight
  • Investors are gearing up for Vistry’s upcoming results and its 2026 outlook

Vistry Group PLC shares dipped on Monday after the housebuilder announced it repurchased 77,600 shares via Peel Hunt, paying between 632.0 pence and 651.4 pence per share. The repurchased shares are set for cancellation. By 1436 GMT, the stock was down 0.6% at 648.6 pence, valuing the company at roughly £2.1 billion. London South East

The filing matters because buybacks cut the number of shares outstanding, which can boost earnings per share if profits stay steady. This comes at a time when the market has been driven almost solely by housing data and interest-rate forecasts.

Since last week’s updates, company news has been sparse. Investors are debating if 2026 volumes will actually rise or merely shift into the back half of the year. Even a minor capital-return announcement can influence positioning when trading is light.

Other UK housebuilders dipped slightly. Persimmon slipped 0.35%, while Taylor Wimpey eased 0.23%, with prices delayed by 15 minutes. London South East

The tone shifted early Monday after Rightmove reported a 2.8% jump in asking prices for new listings in the four weeks to Jan. 10 — the biggest monthly increase since 2015. “It’s an encouraging start to the year,” said Colleen Babcock, Rightmove’s property expert. The company also noted that the number of homes for sale hit its highest level for this time of year since 2014. Reuters

For housebuilders, stronger asking prices boost sentiment and can drive private sales. Yet, an uptick in supply quickly ramps up competition. More listings usually lead to tougher negotiations, especially for builders relying on first-time buyers to maintain moving chains.

Vistry last outlined its fundamentals on Jan. 14, projecting an adjusted profit before tax near £270 million. Revenue was expected to hold steady around £4.2 billion, with net debt roughly £145 million by year-end. CEO Greg Fitzgerald expressed satisfaction with meeting full-year guidance despite ongoing hurdles in the open market — sales to private buyers — and delays in partner-funded projects caused by budget uncertainties. Vistry Group

Buybacks won’t shift the bigger variable: demand. If mortgage rates climb or affordability worsens, a slight uptick in asking prices might not speed up completions. Deals backed by partners can still stall if funding or refinancing dries up.

Vistry’s full-year results, due March 4, will serve as the next major trigger. Investors will focus on cash flow, debt levels, and the management’s outlook for demand in 2026. Vistry Group

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Eli Lilly stock set for Tuesday spotlight as new obesity-pill data ripples through GLP-1 trade
Previous Story

Eli Lilly stock set for Tuesday spotlight as new obesity-pill data ripples through GLP-1 trade

Tesla stock: Canada’s tariff U-turn puts Shanghai exports back in play
Next Story

Tesla stock: Canada’s tariff U-turn puts Shanghai exports back in play

Go toTop